Ongoing FDA Modernization Is Focus Of AdvaMed 2001 Legislative Spotlight
This article was originally published in The Gray Sheet
Executive Summary
A congressional hearing tentatively scheduled to take place by mid-2001 will examine the ability of FDA to approve breakthrough medical technology in a timely fashion, according to the medical device trade group AdvaMed.